Related Experiment Video
Updated: Jul 13, 2026

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
Published on: April 1, 2022
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias
H Buchwald1, J P Matts, L L Fitch
1Department of Surgery, University of Minnesota, Minneapolis 55455.
Insights
Sequential coronary arteriogram changes predict clinical events, offering a prognostic indicator for overall and atherosclerotic coronary heart disease mortality in patients. This aids in atherosclerosis intervention trials.
Area of Science:
- Cardiology
- Medical Imaging
- Interventional Cardiology
Background:
- Atherosclerosis intervention trials require reliable outcome measures.
- Sequential coronary arteriograms offer detailed insights into disease progression.
Purpose of the Study:
- To assess the relationship between changes in sequential coronary arteriograms and subsequent clinical coronary events.
- To determine if arteriographic changes can serve as surrogate endpoints in atherosclerosis trials.
Main Methods:
- A randomized trial (Program on the Surgical Control of the Hyperlipidemias) involving 838 patients.
- Coronary arteriograms were obtained at baseline, 3, 5, and 7/10 years.
- Blinded assessment of arteriographic changes and correlation with clinical events.
Main Results:
- Changes in coronary arteriography significantly predicted overall and atherosclerotic coronary heart disease mortality.
- A strong association was found between arteriographic changes and combined endpoints of mortality or myocardial infarction in both control and surgical groups.
- Stratified analysis revealed significant differences in clinical events based on disease progression.
Conclusions:
- Coronary arteriographic changes are a valid surrogate endpoint for specific clinical events in atherosclerosis trials.
- Arteriographic assessments provide statistically compelling evidence for predicting mortality.
- Changes in coronary atherosclerosis severity serve as prognostic indicators for individual patients.
Objective:
Assessment of the relationship between changes in sequential coronary arteriograms and subsequent clinical coronary events.
Design:
The Program on the Surgical Control of the Hyperlipidemias, a randomized secondary atherosclerosis intervention trial, obtained coronary arteriograms at baseline, 3, 5, and 7 or 10 years of follow-up. Assessments of changes between pairs of coronary arteriograms were made by two-member panels blinded to the patients' assigned treatment and to the temporal sequence of the films. The relationship of changes between the baseline and the 3-year follow-up arteriograms and subsequent clinical coronary events was examined.
Setting:
Three university hospitals and one private primary care facility.
Patients:
A total of 838 patients, with 417 patients randomized to the control group and 421 to the intervention group. Of all patients, 695 had baseline and 3-year arteriograms.
Intervention:
The control group received American Heart Association Phase II diet instruction and the intervention group received identical dietary instruction plus a partial ileal bypass operation.
Main Outcome Measure:
The use of arteriographic changes as a predictor of subsequent clinical coronary events.
Results:
Changes between the baseline and the 3-year coronary arteriographic overall disease assessment were significantly associated with subsequent overall and atherosclerotic coronary heart disease mortality (P less than .01). For the combined end point of atherosclerotic coronary heart disease mortality or confirmed nonfatal myocardial infarction, a significant relationship between the overall disease assessment and subsequent clinical events was found in the control group (P less than .0001) and in the surgery group (P = .04). For this combined end point, however, the control and the surgery groups were different with respect to clinical coronary events after 3 years, stratified by the baseline to 3-year overall disease assessment (P less than .001, unadjusted; P = .06, adjusted for 3-year clinical covariates).
Conclusions:
Coronary arteriographic changes can be used in atherosclerosis intervention trials as a limited surrogate end point for certain clinical coronary events. This relationship is statistically compelling for overall mortality and atherosclerotic coronary heart disease mortality. For an individual patient, changes in the severity of coronary atherosclerosis seen on sequential coronary arteriograms can serve as prognostic indicators for subsequent overall or atherosclerotic coronary heart disease mortality.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Atherosclerosis III: Management
Peripheral Artery Disease V: Postoperative Nursing Management

